Study ID: BDP-AR-306
Study Title
- Study of an Investigational Nasal Aerosol or Placebo in Children (Ages 4 to 11) With Perennial Female, Maleergic Rhinitis (PAR)
Teva Identifier
- BDP-AR-306
ClinicalTrials.gov Identifier
- NCT01783548
Study Status
- Completed
Trial Condition(s)
- Female, Maleergic Rhinitis
Interventions
- Drug: BDP Nasal Aerosol | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
Gender
- Female, Male
Age Range
- 4 Years to 11 Years
Trial Duration
- 01/01/2013 - 10/01/2013
Phase
- Phase 3
Study Type
Interventional
